Welch, John S.
A2 Biotherapeutics, Inc.,
United States
2025 Rank: 90635
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 2467 out of 166615 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 90635 | 101748 |
| Total Cites | 20992 | 22208 |
| H-index | 40 | 40 |
| Hm-index | 9 | 10 |
| Number of Single Authored Papers | 5 | 5 |
| Total Cites to Single Authored Papers | 100 | 102 |
| Number of Single+First Authored Papers | 18 | 18 |
| Total Cites to Single+First Authored Papers | 2922 | 3092 |
| Number of Single+First+Last Authored Papers | 37 | 37 |
| Total Cites to Single+First+Last Authored Papers | 3197 | 3402 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 16892 | 17557 |
| Ratio of Total Citations to Distinct Citing Papers | 1.24 | 1.26 |
| Self-Citation Percentage |
5.48%
|
|
Welch, John S.
Washington University School of Medicine in St. Louis,
United States
2024 Rank: 92464
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 2548 out of 157372 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 92464 | 102323 |
| Total Cites | 19467 | 20601 |
| H-index | 38 | 39 |
| Hm-index | 9 | 10 |
| Number of Single Authored Papers | 5 | 5 |
| Total Cites to Single Authored Papers | 85 | 87 |
| Number of Single+First Authored Papers | 18 | 18 |
| Total Cites to Single+First Authored Papers | 2759 | 2924 |
| Number of Single+First+Last Authored Papers | 36 | 36 |
| Total Cites to Single+First+Last Authored Papers | 2972 | 3171 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 15657 | 16279 |
| Ratio of Total Citations to Distinct Citing Papers | 1.24 | 1.27 |
| Self-Citation Percentage |
5.50%
|
|
Welch, John S.
Washington University School of Medicine in St. Louis,
United States
2023 Rank: 97055
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 2667 out of 147556 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 97055 | 105081 |
| Total Cites | 17844 | 18915 |
| H-index | 36 | 37 |
| Hm-index | 8 | 9 |
| Number of Single Authored Papers | 5 | 5 |
| Total Cites to Single Authored Papers | 77 | 79 |
| Number of Single+First Authored Papers | 18 | 18 |
| Total Cites to Single+First Authored Papers | 2577 | 2737 |
| Number of Single+First+Last Authored Papers | 36 | 36 |
| Total Cites to Single+First+Last Authored Papers | 2727 | 2915 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 14340 | 14914 |
| Ratio of Total Citations to Distinct Citing Papers | 1.24 | 1.27 |
| Self-Citation Percentage |
5.66%
|
|
Welch, John S.
Washington University School of Medicine in St. Louis,
United States
2022 Rank: 99296
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
General & Internal Medicine
Rank in SubField 1: 2777 out of 138599 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 99296 | 111989 |
| Total Cites | 16036 | 16989 |
| H-index | 34 | 35 |
| Hm-index | 8 | 9 |
| Number of Single Authored Papers | 4 | 4 |
| Total Cites to Single Authored Papers | 62 | 62 |
| Number of Single+First Authored Papers | 17 | 17 |
| Total Cites to Single+First Authored Papers | 2348 | 2496 |
| Number of Single+First+Last Authored Papers | 30 | 30 |
| Total Cites to Single+First+Last Authored Papers | 2445 | 2612 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 12862 | 13375 |
| Ratio of Total Citations to Distinct Citing Papers | 1.25 | 1.27 |
| Self-Citation Percentage |
5.61%
|
|